Cancer Treatment:
Cancer news, cancer cure and cancer treatment, Leukemia, cancer information and research on cancer treatment advance.
Ads by Google
-
A Food and Drug Administration (FDA) advisory panel met yesterday to review a novel device that blasts glioblastoma brain tumors with an electrical field. The meeting ended with the committee recommending approval of the NovoTTF-100A System (NovoTTF), noting the benefits outweigh any risks.
-
A malaria drug, chloroquine, has slowed the growth of pancreatic cancer in mice. This discovery by researchers at Dana-Farber Cancer Institute has already prompted clinical trials using hydroxychloroquine, a similar drug, in patients with advanced pancreatic cancer.
-
The CDC Morbidity and Mortality Report, March 11, 2011 shows the number of cancer survivors in the U.S. has hit and all time high. As of 2007, the number of people who have been diagnosed with the disease was 11.7 million, highlighting the need for ongoing follow-up and awareness of long-term needs of cancer survivors who are no longer referred to as cancer victims.
-
Blocking the action of an enzyme that normally promotes immune function could treat lung and pancreatic cancer find researchers. UT Southwestern scientists have discovered cancer growth and survival depends on the enzyme TPK-1 that mutates in 40 percent of lung cancers and 90 percent of pancreatic cancers. The investigators have fund a compound that blocks the enzyme activity in cell cultures and they are now testing the effects on mice.
-
Fish oil supplements may help prevent weight and muscle loss during chemotherapy according to results from a small open-label study. Involuntary weight loss among advanced cancer patients is common. This wasting is a major contributor to poor treatment response, functional decline, and reduced survival.
-
Daffodils are a symbol of hope. You can help the American Cancer Society (ACS) give hope to people facing cancer by supporting their Daffodil Days program.
-
Findings from an analysis of data from the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) shows few physicians refer newly diagnosed eligible patients for cancer clinical trials. Those most likely to do so were medical or radiation oncologists versus surgeons who attended weekly tumor board meetings.
-
Researchers at Queen's Centre for Vision and Vascular Science have identified the role of an important enzyme that leads to heart failure from the effects of chemotherapy. The finding could significantly improve cancer survival rates.Blocking the action of the enzyme, known as NADPH oxidase means higher doses of chemotherapy can be delivered to destroy tumors.
-
Cancer rates in Africa are the focus of a report from the American Cancer Society. The report found cancer prevention resources are lacking and have received little public health attention. The prevalence of AIDS/HIV, tuberculosis and malaria demand attention that makes focusing on cancer prevention more difficult.
-
A new report shows economic development and unhealthy lifestyles contribute to cancer diagnosis and deaths. The combination of an aging and growing population, combined with unhealthy lifestyles such as tobacco smoking, lack of physical activity and poor dietary habits, is blamed for the rise and a shifting trend in diagnosis of cancer.
